APA (7th ed.) Citation

HS, H., SD, K., B, S., U, G., A, S., KJ, K., . . . JM, B. (2016). Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy. Oncoimmunology, 5(12), e1249560. https://doi.org/10.1080/2162402X.2016.1249560

Chicago Style (17th ed.) Citation

HS, Hong, et al. "Distinct Transcriptional Changes in Non-small Cell Lung Cancer Patients Associated with Multi-antigenic RNActive® CV9201 Immunotherapy." Oncoimmunology 5, no. 12 (2016): e1249560. https://doi.org/10.1080/2162402X.2016.1249560.

MLA (9th ed.) Citation

HS, Hong, et al. "Distinct Transcriptional Changes in Non-small Cell Lung Cancer Patients Associated with Multi-antigenic RNActive® CV9201 Immunotherapy." Oncoimmunology, vol. 5, no. 12, 2016, p. e1249560, https://doi.org/10.1080/2162402X.2016.1249560.